2225 related articles for article (PubMed ID: 20670887)
1. Activation of a metabolic gene regulatory network downstream of mTOR complex 1.
Düvel K; Yecies JL; Menon S; Raman P; Lipovsky AI; Souza AL; Triantafellow E; Ma Q; Gorski R; Cleaver S; Vander Heiden MG; MacKeigan JP; Finan PM; Clish CB; Murphy LO; Manning BD
Mol Cell; 2010 Jul; 39(2):171-83. PubMed ID: 20670887
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundances.
Chen X; Zhu Y; Wang Z; Zhu H; Pan Q; Su S; Dong Y; Li L; Zhang H; Wu L; Lou X; Liu S
J Proteomics; 2016 Mar; 136():13-24. PubMed ID: 26844761
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.
Ricoult SJ; Yecies JL; Ben-Sahra I; Manning BD
Oncogene; 2016 Mar; 35(10):1250-60. PubMed ID: 26028026
[TBL] [Abstract][Full Text] [Related]
4. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
5. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
6. Role of S6K1 in regulation of SREBP1c expression in the liver.
Li S; Ogawa W; Emi A; Hayashi K; Senga Y; Nomura K; Hara K; Yu D; Kasuga M
Biochem Biophys Res Commun; 2011 Aug; 412(2):197-202. PubMed ID: 21806970
[TBL] [Abstract][Full Text] [Related]
7. mTOR links oncogenic signaling to tumor cell metabolism.
Yecies JL; Manning BD
J Mol Med (Berl); 2011 Mar; 89(3):221-8. PubMed ID: 21301797
[TBL] [Abstract][Full Text] [Related]
8. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
9. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
[TBL] [Abstract][Full Text] [Related]
11. The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse.
Csibi A; Cornille K; Leibovitch MP; Poupon A; Tintignac LA; Sanchez AM; Leibovitch SA
PLoS One; 2010 Feb; 5(2):e8994. PubMed ID: 20126553
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mTORC1 and its impact on gene expression at a glance.
Laplante M; Sabatini DM
J Cell Sci; 2013 Apr; 126(Pt 8):1713-9. PubMed ID: 23641065
[TBL] [Abstract][Full Text] [Related]
13. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
14. FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1.
Khatri S; Yepiskoposyan H; Gallo CA; Tandon P; Plas DR
J Biol Chem; 2010 May; 285(21):15960-5. PubMed ID: 20371605
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional control of cellular metabolism by mTOR signaling.
Yecies JL; Manning BD
Cancer Res; 2011 Apr; 71(8):2815-20. PubMed ID: 21487041
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.
Laplante M; Sabatini DM
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3281-2. PubMed ID: 20167806
[No Abstract] [Full Text] [Related]
17. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
Yi J; Zhu J; Wu J; Thompson CB; Jiang X
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
[TBL] [Abstract][Full Text] [Related]
18. The expanding role of mTOR in cancer cell growth and proliferation.
Cargnello M; Tcherkezian J; Roux PP
Mutagenesis; 2015 Mar; 30(2):169-76. PubMed ID: 25688110
[TBL] [Abstract][Full Text] [Related]
19. Coordinated regulation of protein synthesis and degradation by mTORC1.
Zhang Y; Nicholatos J; Dreier JR; Ricoult SJ; Widenmaier SB; Hotamisligil GS; Kwiatkowski DJ; Manning BD
Nature; 2014 Sep; 513(7518):440-3. PubMed ID: 25043031
[TBL] [Abstract][Full Text] [Related]
20. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice.
Arif A; Terenzi F; Potdar AA; Jia J; Sacks J; China A; Halawani D; Vasu K; Li X; Brown JM; Chen J; Kozma SC; Thomas G; Fox PL
Nature; 2017 Feb; 542(7641):357-361. PubMed ID: 28178239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
